Patient & Visitor InformationContact Us
  • Melanoma Protocols

    1. CTSU E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon á-2b for Resected High-risk Melanoma
      PI: Maria Constantinou, MD
      Sites: Rhode Island Hospital, The Miriam Hospital

    2. BrUOG 275: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer, and Renal Cancer: A Phase II Brown University Oncology Study
      PI: Maria Constantinou, MD
      Site: The Miriam Hospital, Rhode Island Hospital